Spring Bioscience was founded in 2001 and is headquartered in Pleasanton, California. Led by a team of world-class researchers and scientists, our strategy is to develop a carefully selected portfolio of products that will provide both the research as well as the diagnostic communities with strategic and effective antibody biomarkers for assessing protein expression in tissue. The Spring team complements these antibody products with an elegant selection of advanced detection and ancillary products that are useful in the field of IHC.

Sophisticated Science - The SP1 Estrogen Receptor Example:
Spring antibodies have become renowned for their robust, highly sensitive and specific characteristics. Our focus on tissue pathology also lead to the advent of the first rabbit monoclonal antibodies developed for use in IHC. Many of these “SP” or Spring proprietary clones have subsequently risen to international prominence in their respective areas – the most notable being our SP1 Estrogen Receptor antibody. SP1 is recommended as the gold standard by leading breast cancer pathologists/agencies and is distributed around the world.

Quality First:
Our research and development efforts are underscored by a solid quality infrastructure. We are ISO 13485:2003 certified and maintain a quality system that we utilize to continually improve our products and processes in order to increase customers' satisfaction with our products.

Our Culture:
Spring is a nimble and efficient group, and our culture is one of dialogue and collaboration with our customers and strategic partners. We look forward to assisting industry leaders enhance their research and diagnostic endeavors through the seamless supply of our specialized IHC product lines.